|
|
|
| |
LIFE SCIENCES
|
|
|
|
Ascent Healthcare Solutions
is the leading independent reprocessor of medical devices
for top hospitals and healthcare providers throughout North
America. Since our inception, Ascent customers have safely
reprocessed in excess of 50 million medical devices, eliminating
in excess of 10,000 tons from local landfills, and saving
over $500 million from their costs by reprocessing and recycling
medical products they would otherwise have needlessly thrown
away. Working within strict safety and inspection protocols,
Ascent is constantly pioneering ways to safely improve patient
care by helping healthcare providers maximize limited resources.
Press
|
|
| |
|
| |
AmpliMed® Corporation, a clinical-stage cancer pharmaceutical
company founded by world-renowned oncologists, has a lead
compound, Amplimexon®, in Phase II clinical trials, with
early evidence of efficacy and low levels of toxicity. Disease
targets include pancreatic cancer, lung cancer and melanoma.
The Company also has three promising drug classes in pre-clinical
development, cyanoaziridines, azonafides and benzimate analogues.
The Company is focused on the development of small-molecule
oncology drugs with novel mechanisms of action. The major
effort of the Company is to bring its drugs through Phase
I-III clinical trials as quickly, efficiently and as cost
effectively as possible.
|
 |
| |
|
| |
AzERx acquired by OrthoLogic (NASDAQ:
OLGC), is a biotechnology company committed to developing
a pipeline of novel peptides and other molecules aimed at
helping patients with under-served conditions. The Company
is focused on the development and commercialization of two
product platforms: Chrysalin® (TP508) and AZX100.
Chrysalin, the Company’s novel synthetic peptide, is
being studied in two lead indications, both of which represent
areas of significant unmet medical need – fracture repair
and diabetic foot ulcer healing. Based on the Company’s
pioneering scientific research of the natural healing cascade,
OrthoLogic has become a leading company focused on tissue
and bone repair. The Company owns exclusive worldwide rights
to Chrysalin.
AZX100 is a novel pre-clinical 24-amino acid peptide, the
first of a new class of compounds in the field of smooth muscle
relaxation called Intracellular Actin Relaxing Molecules,
or ICARMs™. AZX100 is currently being evaluated for medically
and commercially significant applications, such as the treatment
of vasospasm associated with subarachnoid hemorrhage, the
prevention of keloid scarring and the treatment of asthma.
OrthoLogic has an exclusive worldwide license to AZX100.
|
 |
| |
|
| |
Now part of the Invitrogen
(NASDAQ: IVGN) family, CellzDirect provides high-quality in
vitro ADME cell products and contract laboratory and consulting
services focused primarily on drug metabolism and transport.
Our clients include leaders in the pharmaceutical, biotech,
academic, chemical and consumer products fields as well as government
agencies. With CellzDirect’s support, scientists conduct
research that accelerates the discovery of safe and effective
drugs.
Press
|
 |
| |
|
|
|
HTG is a Tucson-based company
that has developed a powerful, proprietary "universal
assay" and related products that enable high throughput
drug screening, to help identify gene and other targets,
validate those targets and provide quantitative and qualitative
measurement of toxicity and metabolic effects of chemical
compounds.
Press
|
|
| |
|
| |
Pepgen Corporation, founded in 1992 by
Dr. CP Liu, is based in Alameda, CA. Pepgen is a privately held
biopharmaceutical company seeking to develop and commercialize
novel products for the prevention and treatment of autoimmune
and viral disorders. The company's lead product, Tauferon(tm),
is in Phase II human clinical studies in multiple sclerosis
(MS). Tauferon can be administered orally, which is a significant
improvement over existing therapies, which require frequent,
painful injections. Pepgen is also advancing Neoferon(tm) through
pre-clinical development for the treatment of viral infections
and cancer. |
 |
| |
|
|
|
Regenesis Biomedical is a
Scottsdale-based company in the tissue regeneration business.
Regenesis is engaged in the research and development, manufacture,
sale and marketing of novel electro-magnetic generating
medical device that gives physicians, nurses and physical
therapists the ability to promote healing and skin wound
closure in less time and at a lower cost than the existing
standard of wound care treatments..
Press
|
|
| |
|
| |
Vital Therapies, Inc. (VTI) is a new company formed in 2003
to continue the development of the ELAD® (Extracorporeal
Liver Assist Device) System, which augments the metabolic
functions of a patient’s liver, thereby enabling a bridge
to transplant or liver recovery. VTI acquired the assets and
business of VitaGen/Hepatix.
|
 |
| |
|
|
|
|
|
